Using serological studies to assess COVID-19 infection fatality rate in developing countries: A case study from one Colombian department

This study describe the infection fatality rate (IFR) by COVID-19 by age groups in one department of Colombia. It used results from a serological survey to stablish a closer estimation of the true proportion of infected people. It found an overall IFR of 0.24% quite lower than the overall CFR (5.6%)...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvis Guzman, Nelson, De la Hoz Restrepo, Fernando, Serrano-Coll, Hector, Gastelbondo, Bertha, Mattar, Salim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193972/
https://www.ncbi.nlm.nih.gov/pubmed/34126234
http://dx.doi.org/10.1016/j.ijid.2021.06.018
_version_ 1783706330647756800
author Alvis Guzman, Nelson
De la Hoz Restrepo, Fernando
Serrano-Coll, Hector
Gastelbondo, Bertha
Mattar, Salim
author_facet Alvis Guzman, Nelson
De la Hoz Restrepo, Fernando
Serrano-Coll, Hector
Gastelbondo, Bertha
Mattar, Salim
author_sort Alvis Guzman, Nelson
collection PubMed
description This study describe the infection fatality rate (IFR) by COVID-19 by age groups in one department of Colombia. It used results from a serological survey to stablish a closer estimation of the true proportion of infected people. It found an overall IFR of 0.24% quite lower than the overall CFR (5.6%). We conclude that CFR severely overestimate the lethality of COVID-19 in developing areas.
format Online
Article
Text
id pubmed-8193972
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-81939722021-06-15 Using serological studies to assess COVID-19 infection fatality rate in developing countries: A case study from one Colombian department Alvis Guzman, Nelson De la Hoz Restrepo, Fernando Serrano-Coll, Hector Gastelbondo, Bertha Mattar, Salim Int J Infect Dis Short Communication This study describe the infection fatality rate (IFR) by COVID-19 by age groups in one department of Colombia. It used results from a serological survey to stablish a closer estimation of the true proportion of infected people. It found an overall IFR of 0.24% quite lower than the overall CFR (5.6%). We conclude that CFR severely overestimate the lethality of COVID-19 in developing areas. The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021-09 2021-06-11 /pmc/articles/PMC8193972/ /pubmed/34126234 http://dx.doi.org/10.1016/j.ijid.2021.06.018 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Alvis Guzman, Nelson
De la Hoz Restrepo, Fernando
Serrano-Coll, Hector
Gastelbondo, Bertha
Mattar, Salim
Using serological studies to assess COVID-19 infection fatality rate in developing countries: A case study from one Colombian department
title Using serological studies to assess COVID-19 infection fatality rate in developing countries: A case study from one Colombian department
title_full Using serological studies to assess COVID-19 infection fatality rate in developing countries: A case study from one Colombian department
title_fullStr Using serological studies to assess COVID-19 infection fatality rate in developing countries: A case study from one Colombian department
title_full_unstemmed Using serological studies to assess COVID-19 infection fatality rate in developing countries: A case study from one Colombian department
title_short Using serological studies to assess COVID-19 infection fatality rate in developing countries: A case study from one Colombian department
title_sort using serological studies to assess covid-19 infection fatality rate in developing countries: a case study from one colombian department
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193972/
https://www.ncbi.nlm.nih.gov/pubmed/34126234
http://dx.doi.org/10.1016/j.ijid.2021.06.018
work_keys_str_mv AT alvisguzmannelson usingserologicalstudiestoassesscovid19infectionfatalityrateindevelopingcountriesacasestudyfromonecolombiandepartment
AT delahozrestrepofernando usingserologicalstudiestoassesscovid19infectionfatalityrateindevelopingcountriesacasestudyfromonecolombiandepartment
AT serranocollhector usingserologicalstudiestoassesscovid19infectionfatalityrateindevelopingcountriesacasestudyfromonecolombiandepartment
AT gastelbondobertha usingserologicalstudiestoassesscovid19infectionfatalityrateindevelopingcountriesacasestudyfromonecolombiandepartment
AT mattarsalim usingserologicalstudiestoassesscovid19infectionfatalityrateindevelopingcountriesacasestudyfromonecolombiandepartment

Ejemplares similares